Abiopharma

News list

Eylward Susan 🟡 adjusted position in 0 shares of Imunon, Inc. (IMNN) at $1.65 Transaction Date: Aug 14, 2026 | Filing ID: 028184

Full text

News bot Aug. 17, 2026, 8:18 p.m.
🔍 Eylward Susan (Executive)

Company: Imunon, Inc. (IMNN)

Report Date: 2026-08-14
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 2,449
- Total shares sold: 2,449
Detailed Transactions and Holdings:
- Acquired 2,449 shares of Common Stock at $1.65 per share (Direct)
  Date: 2026-08-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,345.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,449 shares of Common Stock at $1.6303 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,896.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Stock granted in lieu of cash for portion of base salary
- F2: Reflects a weighted average sale price of $1.6303 per share, at prices ranging from $1.61 to $1.655 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.